Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation.
Rosenbeck
Lindsay L
LL
Department of Pharmacy, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Kiel
Patrick J
PJ
Kalsekar
Iftekhar
I
Vargo
Craig
C
Baute
John
J
Sullivan
Cheryl K
CK
Wood
Lisa
L
Abdelqader
Sahar
S
Schwartz
Jennifer
J
Srivastava
Shivani
S
Abonour
Rafat
R
Robertson
Michael J
MJ
Nelson
Robert P
RP
Cornetta
Kenneth
K
Fausel
Christopher A
CA
Farag
Sherif S
SS